the aid library

LIST OPTIONS

Filter

6880

Positive health, dignity and prevention for women and their babies. Flipchart

Inter-Agency Task Team (IATT) (2018) C1

A treatment literacy guide for pregnant women and mothers living with HIV
Positive Health, Dignity and Prevention for Women and their Babies is intended for use by networks of women living with HIV, women’s groups, peer educators and o... more

External Link

MSF Medical Guidelines App

Medécins sans Frontières (2017) C2

This diagnostic and treatment manual is designed for use by medical professionals involved in cura- tive care at the dispensary and hospital levels. We have tried to respond in the s... more

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 3

World Health Organization (WHO) World Health Organization (WHO) (2017) C_WHO

Module 3 Counsellors July 2017 Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or ... counsellors and healthcare workers, including nurses, clinical officers and doctors. more

External Link

Infection Prevention and Control

Dramowski, A. Dave Woods and S. Mehtar; Bettercare (2014) C2

A guide for health professionals in low-resource settings, Infection Prevention and Control is a must-have manual for nurses, doctors, and health a... more

External Link

Communication Toolkit For Migrants, Refugees, and Other Limited-English-Proficient Populations

Centers for Disease Control and Prevention CDC (2021) C_CDC

CDC created this communication toolkit to help public health professionals, health departments, community organizations, and ... systems and providers reach populations who may need COVID-19 prevention messaging in their native languages. more

Download (290)

View PDF (386)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NC... more

External Link

Cervical Cancer Control in India
recommended

ecancer Education; National Cancer Crid, India (2019) CC

A new e-learning course has just been released, aimed at healthcare professionals working with patients in India exploring HPV screening and vaccination, assessment and diagnosis of cervical cancer,... more

Examining nursing practices for management of sepsis in low income countries: the case of Uganda

Aliga C., Mutyabule J., Nakate G., et al. (2018) CC

Examining nursing practice guidelines to improve quality of care for patients with sepsis in low income countries is required. • A large amount of information about best practice standards in sepsis management is available for ... professionals; however, implementation and adherence to practice guidelines recommended by the Surviving Sepsis Campaign remains low in low income countries. more

External Link

National Library of Medicine (NLM) Ebola Articles in Pubmed

National Library of Medicine (2014)

NLM Launches Emergency Access Initiative, Granting Free Access to Books and Journals for Healthcare Professionals Fighting Ebola Outbreak. The National Library of Medicine (NLM) Emergency Access Ini... more

External Link

Clinical Key

Elsevier (2014)

Elsevier Provides Free Online Access to Medical Information for West African Countries Stricken with Ebola Outbreak To support healthcare professionals in West Africa battling the Ebola outbreak, E... more

External Link

Medical Management Guidelines (MMGs)

Agency for Toxic Substances & Disease Registry (2014)

The Medical Management Guidelines (MMGs) for Acute Chemical Exposures were developed by ATSDR to aid emergency department physicians and other emergency healthcare professionals who manage acute exp... more

The National Asthma Education Programme and asthma in Africa

South African Medical Journal; SAMJ (2019) CC2

The National Asthma Education Programme (NAEP) is a registered non-profit organisation whose mission is to provide asthma education to healthcare professionals, patients and the lay public. It was f... more

European Respiratory Society - every breath counts; ERS

European Respiratory Society (2024) CC2

ERS is made up of over 35,000 respiratory clinicians, scientists and allied healthcare professionals, spanning more than 160 countries worldwide. Members are central to the Society and actively part... more

External Link

Managing COVID-19 in General Practice

FutureLearn (2020) C2

Get practical advice and support around how to respond to the novel coronavirus pandemic as a front-line healthcare professional.

Download (301)

View PDF (516)

DHR-ICMR GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF RICKETTSIAL DISEASES IN INDIA

Indian Council of Medical Research (ICMR) (2015) C1

The present DHR-ICMR guidelines comprehensively address the various concerns regarding the clinical assessment, treatment, and laboratory diagnosis of rickettsial diseases in India and the world. It is hoped that physicians, health ... workers, the scientific community, the regulatory agencies, public health care professionals and the public at large will be benefited by these guidelines. more

Download (246)

View PDF (341)

World Alzheimer Report 2019

Prince, M., and J. Jackson Alzheimer's Disease International (2019) C2

Some of the key findings of the report include: Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia 35% of carers across the world said that they have hidden the diagnosis of de... more

External Link

Antimicrobial resistance and the nurse’s role

Agne Diminskyte (2016) C2

Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also statistics reveal that because of antimicrobial resistance patients’ morbidity and mortality is increa... more

External Link

Emotions and feelings in critical and emergency caring situations: a qualitative study

Jiménez-Herrera M.F., Llauradó-Serra M., Acebedo-Urdiales S. et al. (2020) CC

Moral emotions are a key element of our human morals. Emotions play an important role in the caring process. Decision-making and assessment in emergency situations are complex and they frequently result in different emotions and feelings among health... more

External Link

World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update

Freedman, B.; Hindricks, G.; Banerjee, A. Global Heart (2021) CC

The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the... more

Cervical Cancer Control in India recommended

Cervical Cancer Control in India
recommended